Visible and subvisible particles in the BCG immunotherapeutic product Immucyst®.

Electronic counting and sizing of bacteria. Nature (1958) 4.33

Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse. Nature (1959) 3.67

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber Lung Dis (1999) 2.50

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol (2005) 1.84

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol (1995) 1.71

Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination. Toxicon (1999) 0.98